AstraZeneca's bold vision for a cutting-edge vaccine facility in Speke is caught in a web of delays, leaving the biotech ...
AstraZeneca share rose after it that the company has secured permission to import pharmaceutical formulations of new drug for ...
AstraZeneca has received two positive recommendations from the National Institute for Health and Care Excellence (NICE) for ...
News Medical on MSN1d
AstraZeneca receives positive NICE recommendations for lung cancer treatmentAstraZeneca announced that this week it has received two positive recommendations from the National Institute for Health and Care Excellence (NICE) for the treatment of lung cancer patients across ...
10d
Britain led the world in developing Covid-19 vaccines but former Health Secretary Matt Hancock says the NHS crisis means ...
Drugmakers are growing frustrated with the National Health Service after a clawback tax unexpectedly soared, with ...
Sir Chris Whitty tells the Covid-19 Inquiry the NHS has 'slipped backwards' since the pandemic at sharing vital patient data, ...
But the team behind the Oxford/AstraZeneca coronavirus jab has now reported progress in its work on an inoculation. Three of the world’s seven known pandemics have been caused by the plague ...
J.P. Morgan analyst James Gordon maintained a Buy rating on AstraZeneca (AZN – Research Report) today and set a price target of £140.00. The ...
COVID-19 vaccines were not associated with increased risk for thyroid diseases but were associated with increased risk for exacerbated hypothyroidism.
AstraZeneca announced that this week it has received two positive recommendations from the National Institute for Health and Care Excellence (NICE) for the treatment of lung cancer patients across ...
The British House of Commons approved the trade agreement with the European Union yesterday in a 521-73 vote, ending the Brexit saga just before th ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback